SOPHiA GENETICS (SOPH) Non Operating Interest Expenses (2023 - 2026)

SOPHiA GENETICS has disclosed Non Operating Interest Expenses across 4 years of filings, most recently posting -$1.6 million for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses fell 189.8% year-over-year to -$1.6 million; the TTM figure through Jun 2026 stood at -$6.6 million (down 166.3% YoY), while the FY2025 annual figure was -$4.6 million, down 138.06% from the prior year.
• Non Operating Interest Expenses came in at -$1.6 million for Q2 2026 at SOPHiA GENETICS, up from -$1.7 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $150000.0 in Q4 2023 to a low of -$1.7 million in Q4 2025.
• Average Non Operating Interest Expenses over 4 years is -$873090.9, with a median of -$659000.0 recorded in 2025.
• Year-over-year, Non Operating Interest Expenses slumped 554.0% in 2024 and decreased 11.58% in 2025.
• Over 4 years, Non Operating Interest Expenses stood at $150000.0 in 2023, then tumbled by 554.0% to -$681000.0 in 2024, then plunged by 145.67% to -$1.7 million in 2025, then advanced by 3.17% to -$1.6 million in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were -$1.6 million in Q2 2026, -$1.7 million in Q1 2026, and -$1.7 million in Q4 2025.